Careteq Stock Forecast for 2023 - 2025 - 2030
Updated on 05/06/2024
Careteq Stock Forecast and Price Target
The average price target for Careteq's stock set by recognized analysts recently is $0.08, which would result in a potential upside of approximately 700% if it reached this mark. The estimation is based on a high estimate of $0.08 and a low estimate of $0.08. Even if you are not interested in CTQ stock, you should still be aware of its competitors.
700.00% Upside
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
SIE Stock Forecast | Siemens | Outperform |
10
|
177.62€ | Buy/Sell | 178.14€ | 10.07% |
HON Stock Forecast | Honeywell International Inc | Outperform |
12
|
$195.81 | Buy/Sell | $219.12 | 13.38% |
CVS Stock Forecast | CVS Health | Outperform |
12
|
$55.90 | Buy/Sell | $89.54 | 25.22% |
6752 Stock Forecast | Panasonic Holdings | Outperform |
17
|
¥1.42k | Buy/Sell | ¥1.91k | 38.51% |
ICR Stock Forecast | Intelicare Holdings | - |
0
|
$0.01 | Buy/Sell | $0.47 | -100.00% |
Careteq Revenue Forecast for 2023 - 2025 - 2030
In the last year, Careteq's Revenue has seen an increase, rising from $5.24M to $6.35M. This represents a growth of 21.18%. For the next year, 0 analysts project Careteq's Revenue to drop by 17.48%, reaching $5.24M. By 2030, professionals believe that Careteq's Revenue will decrease by 11.04%, reaching $5.65M – a concerning trend for the company.
Careteq EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Careteq's EBITDA has seen a drop from $-4.09M to $-3.57M – a 12.71% decrease. In the next year, analysts predict that EBITDA will reach $-4.09M – an increase of 14.57%. For the next seven years, the forecast is for EBITDA to grow by 11.18%.
Careteq EBIT Forecast for 2023 - 2025 - 2030
In the last year, Careteq's EBIT has gone down from $-4.10M to $-3.93M – a 4.15% drop. In the next year, analysts are expecting an increase in EBIT, predicting it will reach $-4.10M – an increase of 4.33%. The Careteq forecast is for EBIT to reach $-4.05M or grow by 3.15%.